Ye Lin

2.4k total citations
59 papers, 1.5k citations indexed

About

Ye Lin is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Ye Lin has authored 59 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 19 papers in Molecular Biology and 16 papers in Surgery. Recurrent topics in Ye Lin's work include Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Ye Lin is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Ye Lin collaborates with scholars based in China, United States and United Kingdom. Ye Lin's co-authors include Haosheng Jin, Zhixiang Jian, Min Yu, Zhixiang Jian, Guanqun Huang, Baohua Hou, Renguo Guan, Peiqing Li, Chong Wang and Xianhan Jiang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Ye Lin

57 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ye Lin China 21 790 674 352 300 235 59 1.5k
Guanqun Li China 18 410 0.5× 220 0.3× 248 0.7× 168 0.6× 124 0.5× 51 860
Menha Swellam Egypt 22 627 0.8× 512 0.8× 184 0.5× 273 0.9× 83 0.4× 71 1.1k
Xiaoshun He China 23 1.6k 2.0× 982 1.5× 339 1.0× 511 1.7× 221 0.9× 115 2.6k
Ioan Jung Romania 20 396 0.5× 260 0.4× 517 1.5× 326 1.1× 299 1.3× 113 1.3k
Le Qu China 20 884 1.1× 644 1.0× 234 0.7× 153 0.5× 415 1.8× 61 1.4k
Kazumasa Komura Japan 20 525 0.7× 390 0.6× 296 0.8× 287 1.0× 380 1.6× 95 1.2k
Kunlin Xie China 19 827 1.0× 635 0.9× 293 0.8× 196 0.7× 134 0.6× 46 1.3k
Lei Cai China 19 510 0.6× 348 0.5× 691 2.0× 300 1.0× 250 1.1× 53 1.3k
Ioannis Diamantis Switzerland 20 374 0.5× 147 0.2× 240 0.7× 245 0.8× 154 0.7× 48 1.2k
Maria Matsangou United States 16 631 0.8× 248 0.4× 804 2.3× 703 2.3× 419 1.8× 42 1.8k

Countries citing papers authored by Ye Lin

Since Specialization
Citations

This map shows the geographic impact of Ye Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Lin more than expected).

Fields of papers citing papers by Ye Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Lin. The network helps show where Ye Lin may publish in the future.

Co-authorship network of co-authors of Ye Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Lin. A scholar is included among the top collaborators of Ye Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Lin. Ye Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Ye, et al.. (2025). Case Report: Successful immune checkpoint inhibitor rechallenge after sintilimab-induced Guillain-Barré syndrome. Frontiers in Immunology. 16. 1546886–1546886. 2 indexed citations
2.
Lin, Ye, Zhongwu Bei, Tingyu Yang, et al.. (2025). A dissolving microneedle patch enables minimally invasive riboflavin delivery and enhances corneal crosslinking in keratoconus therapy. Journal of Materials Chemistry B. 13(18). 5343–5357. 1 indexed citations
4.
Lin, Ye, Ning An, H. Wu, et al.. (2024). Macrophage autophagy protects against acute kidney injury by inhibiting renal inflammation through the degradation of TARM1. Autophagy. 21(1). 120–140. 20 indexed citations
5.
Wang, Xiaoqing, Yunyun Xiao, Xinjian Huang, et al.. (2023). The phospholipid flippase ATP9A enhances macropinocytosis to promote nutrient starvation tolerance in hepatocellular carcinoma. The Journal of Pathology. 260(1). 17–31. 6 indexed citations
6.
Zou, Yiping, et al.. (2023). Construction and validation of chemoresistance-associated tumor- infiltrating exhausted-like CD8+ T cell signature in breast cancer: cr-TILCD8TSig. Frontiers in Immunology. 14. 1120886–1120886. 6 indexed citations
7.
Guan, Renguo, et al.. (2022). Microvascular Invasion in Hepatocellular Carcinoma: A Review of Its Definition, Clinical Significance, and Comprehensive Management. Journal of Oncology. 2022. 1–10. 33 indexed citations
8.
Guan, Renguo, Yiping Zou, Zhixiang Jian, et al.. (2022). Nomogram Based on Inflammatory Biomarkers to Predict the Recurrence of Hepatocellular Carcinoma—A Multicentre Experience. Journal of Inflammation Research. Volume 15. 5089–5102. 13 indexed citations
9.
Lin, Shuwen, et al.. (2021). Meta-analysis of the prognostic value of pretreatment serum ferritin in hepatobiliary and pancreas (HBP) cancers. BMJ Open. 11(5). e040801–e040801. 5 indexed citations
10.
Lin, Shuwen, et al.. (2021). circRPS16 Promotes Proliferation and Invasion of Hepatocellular Carcinoma by Sponging miR-876-5p to Upregulate SPINK1. Frontiers in Oncology. 11. 724415–724415. 7 indexed citations
11.
Guan, Renguo, Weimin Guo, Weifeng Hong, et al.. (2020). Identification of Aberrantly Methylated Differentially CpG Sites in Hepatocellular Carcinoma and Their Association With Patient Survival. Frontiers in Oncology. 10. 1031–1031. 2 indexed citations
12.
Lan, Bo, Ye Lin, Jiayang Chen, et al.. (2020). Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis. Digestive Diseases and Sciences. 66(9). 3074–3085. 18 indexed citations
13.
Yu, Min, Weifeng Hong, Yujun Gu, et al.. (2019). Prognostic role of glycolysis for cancer outcome: evidence from 86 studies. Journal of Cancer Research and Clinical Oncology. 145(4). 967–999. 61 indexed citations
14.
Yu, Min, Bowen Huang, Ye Lin, et al.. (2019). Acute obstructive cholangitis due to fishbone in the common bile duct: a case report and review of the literature. BMC Gastroenterology. 19(1). 177–177. 6 indexed citations
16.
Zeng, Li, et al.. (2019). Short-term Outcomes of Laparoscopic vs. Open Hepatectomy for Primary Hepatocellular Carcinoma: A Prospective Comparative Study. Current Medical Science. 39(5). 778–783. 5 indexed citations
17.
Huang, Guanqun, et al.. (2018). Prognostic value of plasma fibrinogen in hepatocellular carcinoma: a meta-analysis. Cancer Management and Research. Volume 10. 5027–5041. 27 indexed citations
18.
Lin, Ye, et al.. (2014). Endoscopic minimal invasive cholecystolithotomy vs laparoscopic cholecystectomy in treatment of cholecystolithiasis in China: A meta-analysis. International Journal of Surgery. 13. 227–238. 20 indexed citations
19.
Liu, Xinghua, Bo Zhang, Yan Guo, et al.. (2011). The overexpression of AP-4 as a prognostic indicator for gastric carcinoma. Medical Oncology. 29(2). 871–877. 28 indexed citations
20.
Lin, Ye, Soo Khim Chan, Yu‐Hua Chow, Lap-Chee Tsui, & Jim Hu. (2001). Regulated Expression of the Human CFTR Gene in Epithelial Cells. Molecular Therapy. 3(5). 723–733. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026